• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝脏在 CT 增强扫描中的强化表现:是否存在超出机构对比剂量限制后与体重相关的依赖性?

Hepatic enhancement at computed tomography: is there a dependence on body weight past institutional contrast dosing limits?

机构信息

Division of Radiology, Department of Clinical Science, 206106Intervention and Technology at Karolinska Institutet, Stockholm, Sweden.

Department of Radiology, 379654Södersjukhuset, Stockholm, Sweden.

出版信息

Acta Radiol. 2023 Feb;64(2):435-440. doi: 10.1177/02841851221079014. Epub 2022 Mar 10.

DOI:10.1177/02841851221079014
PMID:35266404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9905147/
Abstract

BACKGROUND

Although described in product monographs, the maximum contrast media (CM) dose at computed tomography (CT) varies among institutions.

PURPOSE

To investigate whether an upper limit of 40 g of iodine in women and 50 g in men is sufficient or if there is a body weight (BW) dependence of mean hepatic enhancement (MHE) beyond those thresholds.

MATERIAL AND METHODS

At our institution, CM injection duration is fixed to 30 s and dosed 600 mg iodine/kg up to 40 g in women and 50 g in men. Pre- and post-contrast hepatic attenuation values (HU) were retrospectively obtained in 200 women and 200 men with glomerular filtration rate >45 mL/min undergoing 18-flurodeoxyglucose PET-CT (18F-FDG PET-CT) of which half weighed below and half above those dose thresholds using iodixanol 320 mg iodine/mL or iomeprol 400 mg iodine/mL. The correlation between BW and MHE was assessed by simple linear regression.

RESULTS

Weight range was 41-120 kg in women and 47-137 kg in men. There was no significant relationship between MHE and BW in women receiving <40 g (r = -0.05,  = 0.63) or in men receiving <50 g (r = 0.18,  = 0.07). Above those thresholds there was an inverse relationship (r = -0.64, <0.001 in women and r = -0.30, <0.002 in men). There was no apparent upper limit where the dependence of hepatic MHE on BW decreased. Hepatosteatosis limited MHE.

CONCLUSION

Adjusting CM to BW diminishes the dependence of MHE on BW. There was no apparent upper limit for the relationship between BW and MHE in heavier patients at CM-enhanced CT.

摘要

背景

尽管在产品说明书中有所描述,但计算机断层扫描(CT)的最大造影剂(CM)剂量在不同机构之间有所差异。

目的

研究女性最大碘摄入量为 40g,男性最大碘摄入量为 50g 是否足够,或者在这些阈值之外,肝平均增强(MHE)是否与体重(BW)存在依赖关系。

材料与方法

在本机构,CM 注射时间固定为 30s,女性最大碘摄入量为 40g,男性最大碘摄入量为 50g,按 600mg 碘/kg 进行剂量注射。回顾性分析了 200 名肾小球滤过率(GFR)>45ml/min 的女性和 200 名男性患者的肝衰减值(HU),这些患者行 18-氟代脱氧葡萄糖正电子发射断层扫描(18F-FDG PET-CT),其中一半患者的体重低于或高于碘克沙醇 320mg 碘/ml 或碘普罗胺 400mg 碘/ml 的剂量阈值。采用简单线性回归评估 BW 与 MHE 的相关性。

结果

女性的体重范围为 41-120kg,男性的体重范围为 47-137kg。在女性中,当接受碘摄入量<40g 时(r=-0.05,P=0.63)或男性接受碘摄入量<50g 时(r=0.18,P=0.07),MHE 与 BW 之间无显著相关性。在这些阈值之上,存在一种负相关关系(r=-0.64,P<0.001,女性;r=-0.30,P<0.002,男性)。MHE 对 BW 的依赖性似乎没有明显的上限。肝脂肪变性限制了 MHE。

结论

按 BW 调整 CM 剂量可降低 MHE 对 BW 的依赖性。在 CM 增强 CT 中,较重患者的 BW 与 MHE 之间的关系不存在明显的上限。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/914e/9905147/ec2cacccad66/10.1177_02841851221079014-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/914e/9905147/81bc8868ddb5/10.1177_02841851221079014-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/914e/9905147/29430652aeeb/10.1177_02841851221079014-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/914e/9905147/ec2cacccad66/10.1177_02841851221079014-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/914e/9905147/81bc8868ddb5/10.1177_02841851221079014-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/914e/9905147/29430652aeeb/10.1177_02841851221079014-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/914e/9905147/ec2cacccad66/10.1177_02841851221079014-fig3.jpg

相似文献

1
Hepatic enhancement at computed tomography: is there a dependence on body weight past institutional contrast dosing limits?肝脏在 CT 增强扫描中的强化表现:是否存在超出机构对比剂量限制后与体重相关的依赖性?
Acta Radiol. 2023 Feb;64(2):435-440. doi: 10.1177/02841851221079014. Epub 2022 Mar 10.
2
Contrast media injection protocol for portovenous phase abdominal CT: does a fixed injection duration improve hepatic enhancement over a fixed injection rate?腹部CT门静脉期造影剂注射方案:固定注射持续时间相比固定注射速率是否能改善肝脏强化效果?
Abdom Radiol (NY). 2021 Jun;46(6):2968-2975. doi: 10.1007/s00261-020-02919-3. Epub 2021 Jan 2.
3
Dosing Iodinated Contrast Media According to Lean Versus Total Body Weight at Abdominal CT: A Stratified Randomized Controlled Trial.根据腹部 CT 检查时的瘦体重与总体重给碘对比剂进行给药:一项分层随机对照试验。
Acad Radiol. 2020 Jun;27(6):833-840. doi: 10.1016/j.acra.2019.07.014. Epub 2019 Aug 19.
4
The influence of body mass index and gender on coronary arterial attenuation with fixed iodine load per body weight at dual-source CT coronary angiography.在双源CT冠状动脉造影中,体重指数和性别对每单位体重固定碘负荷下冠状动脉衰减的影响。
Acta Radiol. 2012 Jul;53(6):637-42. doi: 10.1258/ar.2012.110657.
5
Body size indexes for optimizing iodine dose for aortic and hepatic enhancement at multidetector CT: comparison of total body weight, lean body weight, and blood volume.体表面积指数用于优化多排 CT 主动脉和肝增强碘剂量:体质量、去脂体质量和血容量的比较。
Radiology. 2010 Jan;254(1):163-9. doi: 10.1148/radiol.09090369. Epub 2009 Dec 17.
6
Minimally Required Iodine Dose for the Detection of Hypervascular Hepatocellular Carcinoma on 80-kVp CT.80千伏峰值CT检测富血供肝细胞癌所需的最低碘剂量
AJR Am J Roentgenol. 2016 Mar;206(3):518-25. doi: 10.2214/AJR.15.15138.
7
Body size indices to determine iodine mass with contrast-enhanced multi-detector computed tomography of the upper abdomen: does body surface area outperform total body weight or lean body weight?用腹部多层螺旋 CT 增强扫描测量碘质量的体表面积指数:体表面积优于体重还是去脂体重?
Eur Radiol. 2013 Jul;23(7):1855-61. doi: 10.1007/s00330-013-2808-z. Epub 2013 Mar 19.
8
Abdominal multidetector CT in patients with varying body fat percentages: estimation of optimal contrast material dose.不同体脂百分比患者的腹部多排CT:最佳对比剂剂量的估算
Radiology. 2008 Dec;249(3):872-7. doi: 10.1148/radiol.2492080033. Epub 2008 Oct 21.
9
Improvement in arterial enhancement using diluted injection of contrast medium in CT angiography.在CT血管造影中使用稀释造影剂注射改善动脉强化。
Acta Radiol. 2023 Feb;64(2):489-495. doi: 10.1177/02841851221077400. Epub 2022 Feb 18.
10
Aortic and hepatic contrast enhancement with abdominal 64-MDCT in pediatric patients: effect of body weight and iodine dose.儿童患者腹部64层螺旋CT主动脉和肝脏的对比增强:体重和碘剂量的影响
AJR Am J Roentgenol. 2008 Nov;191(5):1589-94. doi: 10.2214/AJR.07.3576.

引用本文的文献

1
Validation of a multi-parameter algorithm for personalized contrast injection protocol in liver CT.肝脏 CT 个性化对比注射方案的多参数算法验证。
Eur Radiol Exp. 2024 Oct 9;8(1):112. doi: 10.1186/s41747-024-00492-8.

本文引用的文献

1
Low incidence of nephrotoxicity following intravenous administration of iodinated contrast media: a prospective study.静脉注射碘造影剂后肾毒性发生率低:一项前瞻性研究。
Eur Radiol. 2019 Jul;29(7):3927-3934. doi: 10.1007/s00330-019-06147-2. Epub 2019 Apr 11.
2
Preventing contrast medium-induced acute kidney injury : Side-by-side comparison of Swedish-ESUR guidelines.预防对比剂诱导的急性肾损伤:瑞典 ESUR 指南并排比较。
Eur Radiol. 2018 Dec;28(12):5384-5395. doi: 10.1007/s00330-018-5678-6. Epub 2018 Aug 21.
3
Post-contrast acute kidney injury - Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors : Recommendations for updated ESUR Contrast Medium Safety Committee guidelines.
对比剂后急性肾损伤-第 1 部分:定义、临床特征、发生率、对比剂的作用及危险因素:对 ESUR 对比剂安全委员会指南更新的建议。
Eur Radiol. 2018 Jul;28(7):2845-2855. doi: 10.1007/s00330-017-5246-5. Epub 2018 Feb 9.
4
Acute kidney injury in patients with nephrotic syndrome undergoing contrast-enhanced CT for suspected venous thromboembolism: a propensity score-matched retrospective cohort study.肾病综合征患者疑诊静脉血栓栓塞行增强 CT 检查后发生急性肾损伤:一项倾向评分匹配的回顾性队列研究。
Eur Radiol. 2018 Apr;28(4):1585-1593. doi: 10.1007/s00330-017-5109-0. Epub 2017 Nov 2.
5
Assessment of Cirrhotic Liver Enhancement With Multiphasic Computed Tomography Using a Faster Injection Rate, Late Arterial Phase, and Weight-Based Contrast Dosing.使用更快注射速率、延迟动脉期和基于体重的对比剂剂量的多期计算机断层扫描评估肝硬化肝脏强化情况。
Can Assoc Radiol J. 2017 Nov;68(4):371-378. doi: 10.1016/j.carj.2017.01.001. Epub 2017 Jul 15.
6
Comparison between a fixed-dose contrast protocol and a weight-based contrast dosing protocol in abdominal CT.腹部CT中固定剂量对比剂方案与基于体重的对比剂给药方案的比较。
Clin Radiol. 2016 Dec;71(12):1314.e1-1314.e9. doi: 10.1016/j.crad.2016.07.009. Epub 2016 Aug 21.
7
Incidence, clinical presentation and mortality of liver cirrhosis in Southern Sweden: a 10-year population-based study.瑞典南部肝硬化的发病率、临床表现和死亡率:一项基于人群的 10 年研究。
Aliment Pharmacol Ther. 2016 Jun;43(12):1330-9. doi: 10.1111/apt.13635. Epub 2016 Apr 19.
8
The Optimal Body Size Index with Which to Determine Iodine Dose for Hepatic Dynamic CT: A Prospective Multicenter Study.用于确定肝脏动态 CT 碘剂量的最佳体表面积指数:一项前瞻性多中心研究。
Radiology. 2016 Mar;278(3):773-81. doi: 10.1148/radiol.2015142941. Epub 2015 Sep 10.
9
Imaging Techniques for the Diagnosis of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.用于肝细胞癌诊断的影像学技术:系统评价和荟萃分析。
Ann Intern Med. 2015 May 19;162(10):697-711. doi: 10.7326/M14-2509.
10
Body size indices to determine iodine mass with contrast-enhanced multi-detector computed tomography of the upper abdomen: does body surface area outperform total body weight or lean body weight?用腹部多层螺旋 CT 增强扫描测量碘质量的体表面积指数:体表面积优于体重还是去脂体重?
Eur Radiol. 2013 Jul;23(7):1855-61. doi: 10.1007/s00330-013-2808-z. Epub 2013 Mar 19.